Sensorion: reporting of the General Assembly. pdfRead

Sensorion announces the signature of a partnership framework agreement with Institut Pasteur on Gene Therapy programs targeting hearing loss. pdfRead

Sensorion announces oral presentation at the European Histamine Research Society. pdfRead

Sensorion announces the positive Data Safety Monitoring Board (DSMB) review and continuation of the phase 2 clinical trial for SENS-111 in acute unilateral vestibulopathy (AUV). 86 patients enrolled in SENS-111 clinical trial. pdfRead

Sensorion’s 2018 financial report is now available. pdfRead

Pipeline

20190603 pipeline

Enregistrer

Patient center

Corporate presentation

Next events